Preliminary analysis indicated that a 19-amino-acid peptide sequence (435 to 453 of GtfC) within a highly conserved region of the glucosyltransferases of the cariogenic streptococci might be functionally important
water-soluble glucan exclusively. Furthermore, the in vitro sucrose-dependent adherence of Streptococcus mutans was also inhibited by CJSm18-S3 in a dose-dependent manner. Our results indicate that the peptide containing the N-terminal conserved region of glucosyltransferases is functionally important for both enzymatic activity and bacterial adherence.
Streptococcus mutans is an important pathogen for human dental caries (21) . One of its virulence traits is the synthesis of glucan polymers, which mediate the attachment of bacteria to smooth surfaces and consequently the formation of dental plaque (11) . Glucosyltransferases (GTFs) are enzymes responsible for the synthesis of water-soluble and -insoluble glucan. In S. mutans, GTFs are encoded by three genes, gtfB, gtfC, and g#D, which express different enzyme activities (2, 13, 14) . GtfB (GTF-I; 162 kDa) and GtfC (GTF-SI; 149 kDa) synthesize insoluble glucan (2, 13) and low-molecular-weight soluble glucan (9, 13) , respectively, in a primer-independent manner, while GtfD (GTF-S; 155 kDa) synthesizes water-soluble glucan exclusively in a primerdependent manner (14) . GtfB and GtfC have a high degree of amino acid sequence identity. In addition, homologous GTFs are found in other mutans streptococci, such as Gtfl from Streptococcus downei MFe28 and Gtf-I from Streptococcus sobrinus 6715 (1, 8, 27, 30) .
Studies of the structure and function relationships of the GTFs via deletion clones have revealed several important peptide regions. The deletion study of Gtfl from S. downei MFe28 has demonstrated that the direct repeat units at the C-terminal region are responsible for glucan binding (8) . A similar study of Gtf-I from S. sobrinus showed that the N-terminal 80 amino acids were nonessential for enzymatic activity. However, the loss of 260 amino acids from the N terminus of Gtf-I by further deletion diminished the enzyme activities for sucrose splitting and glucan synthesis, although glucan binding was not affected because of an intact C terminus (1) . Furthermore, it has been shown that antiserum to a chimeric protein composed of 15 amino acids of the N terminus of GtfB (342 to 356) and the B subunit of cholera toxin inhibited the water-insoluble glucan synthesis of a * Corresponding author.
crude enzyme prepared from a culture supernatant of S. mutans . Recently, an active site responsible for sucrose binding was proposed after sequencing of a peptide from the stabilized glucosyl-enzyme complex (24, 25) and confirmed by site-directed mutagenesis (16) . This peptide of nine amino acids is located in the N-terminal one-third of the GTFs. Together, these results suggested that the N terminus of the GTFs may play a central role in the enzymatic activities for sucrose splitting and glucan synthesis.
Using restriction fragment length polymorphism analysis, we have initially identified genetic variations in the gtB and gtfC genes among serotype c and e strains of S. mutans (3, 5) . One of the variations abolished an EcoRI endonuclease site in the 5' coding regions of these two genes. The polymorphisms of the GTFs, although variable in DNA sequence, did not affect the enzymatic activities or the sucrose-dependent adherence of the S. mutans strains (3). More recently, we have sequenced the 5' EcoRI regions in the g#B and gtfC genes and confirmed that the DNA polymorphisms were due to point mutations. In addition, nucleotide substitutions in different strains are of a conservative nature, not affecting the encoded amino acids (4) . A synthetic peptide of 19 amino acids from this region, corresponding to residues 435 to 453 of GtfC, was able to reverse the inhibition of the enzyme activities by a polyclonal antibody raised against partially purified GtfB and GtfC proteins (4) . A higher dose of the synthetic peptide incubated alone with GtfC or GtfD had no effect on the enzymatic activities. The selected 19-amino-acid sequence is identical among the GTFs from several mutans streptococci (1, 8, 10, 15, 27, 30) and is very close to the reported active-site sequence for sucrose binding (16 (15, 27, 30) , Gtfl and GtfS from S. downei MFe28 (8, 10) , and Gtf-I from S. sobrinus 6715 (1). The numbers refer to the first amino acid of each peptide. The amino acid sequences were aligned and analyzed with the Genetics Computer Group Sequence Analysis software package (7) . Amino acids which are identical or conserved among the GTFs are boxed. The 19-amino-acid peptide (underlined in GtfB) used for generation of the MAb is shared by all GTFs.
The GtfC expressed from an Escherichia coli(pNH3) strain and GtfD secreted from S. mutans NHS1 (13) were purified and used for functional assays. The inhibitory effects of the antipeptide MAbs on the enzymatic activities of the GTFs and on the in vitro sucrose-dependent adherence of S. mutans were demonstrated. The possible role of the peptide in GTFs is discussed. [Difco] , and 5 g of NaCl per liter) containing ampicillin (100 ,ug/ml). S. mutans GS-5 and MT-8148 were grown and maintained as described previously (3). S. mutans NHS1, a mutant strain of GS-5 with both the gtfl and gtfC genes deleted (13) , was grown and maintained as described previously (4).
MATERIALS AND METHODS
Preparation of immunogen. A peptide of 19 residues (ANDVDNSNPVVQAEQLNWL) (Fig. 1 given another booster of a similar dose in Freund's incomplete adjuvant. High-titer antisera were collected at appropriate times, and the spleens were used for fusion.
ELISA. Peptide-specific MAbs were detected by an ELISA as described below. The 96-well polystyrene enzyme immunoassay plates (GIBCO Laboratories, Grand Island, N.Y.) were used for all reactions. Between steps, wells were washed three times with an automatic washer (Tri-Continent Scientific Inc., Grass Valley, Calif.) at room temperature with 0.05% Tween 20 in PBS (pH 7.4). The wells were coated with peptide (100 ,ug/ml in PBS, pH 7.4) or protein (25 ,ug/ml in sodium carbonate buffer, pH 9.8) and incubated overnight at 4°C, and 150 ,ul of blocking agent (0.25% gelatin [Sigma]) was added for 2 h at 37°C. The antibody to be tested was then added and incubated for 1 h. Antibody that reacted with the coated peptide or proteins was detected with alkaline phosphatase-labeled goat anti-mouse immunoglobulin G (IgG; Sigma) and then with a p-nitrophenylphosphate substrate (Sigma). Responses were measured in a microplate reader (Tri-Continent Scientific Inc.) at 405 nm, and the reactivity was compared with that of the appropriate controls.
Production and purification of MAb. Murine hybridomas were generated as described previously (19) . Briefly, 5 days after the last immunization, spleens were removed aseptically, and the cells were fused with myeloma cells (P3-X63-Ag; American Type Culture Collection [ATCC]) in 50% polyethylene glycol (4,000 molecular weight; GIBCO). After fusion, the cell mixture was plated onto 96-well microtiter plates (Costar, Cambridge, Mass.) and grown in RPMI 1640 medium (150 p,l per well) supplemented with 10% fetal calf serum, 2-mercaptoethanol (3 x 10' M), and L-glutamine (2 X 10-4 M) plus antibiotics. The next day, cultured cells were grown in selection medium containing hypoxanthine, aminopterin, and thymidine for 10 days. The culture supernatants were subsequently assayed for peptide-specific antibodies by ELISA. Peptide-specific hybridomas were then cloned twice by limiting dilution (0.5 cell per well) in 96-well U-bottomed plates (Costar). One of the six positive clones, CJSm18-S3, was characterized further and injected into BALB/c mice (2 x 107 cells per mouse) which had been treated with 2,6,10,14-tetramethylpentadecane for the generation of ascites. Specific IgG was purified from the ascites of CJSm18-S3 by affinity chromatography with the ImmunoPure (IgG) Purification Kit (Pierce Chemical Co., Rockford, Ill.). Antibody specificity was tested by ELISA and immunoblot.
Purification of GTFs. GtfD was purified from an S. mutans strain (NHS1) lacking both GtfB and GtfC (13) as described previously (4) . GtfB and GtfC from S. mutans GS-SDD (14) , in which GtfD is inactivated, were separated from other proteins after two column chromatographies and was defined as partially purified GtfB/C, because this preparation contained both GtfB and GtfC (4). Recombinant GtfC expressed from E. coli harboring pNH3 (13) 6 .5, while the Km for sucrose was estimated to be 9.2 mM. These properties were similar to those described previously (9, 13). The GtfB expressed from an E. coli strain harboring pSU20 (3) from our collections was also extracted and solubilized by the same procedures as for GtfC. The extracted GtfB was found to be biologically active but in low yield. The GtfB extracts were partially purified by DEAE-Sephacel column chromatography, and the fractions showing enzymatic activity were concentrated by Centricon-100 microconcentrators and defined as crude preparations of GtfB. This partially purified crude GtfB was biologically active and did not contain the truncated GtfC protein which was also encoded by pSU20, as confirmed by Western blot (immunoblot) analyses with PJS-3 and PJS-2 antisera (4).
Enzyme and protein assays. GTF activity was determined by the [14C]glucose-sucrose (New England Nuclear Corp., Boston, Mass.) incorporation assay as described previously (20) . Briefly, the reaction mixture consisted of enzyme, 2.9 mM labeled sucrose (0.017 ,Ci/mmol), and 0.10 M potassium phosphate buffer (pH 6.0) plus dextran T10 (for GtfD), in a total volume of 0.5 ml. The reaction mixtures were incubated at 37°C for 1 h, and synthesis was terminated by the addition of 5 ml of methanol (for total glucan synthetic activity) or by heating at 100°C for S min (for insolubleglucan synthesis). The methanol-precipitated samples were filtered through 2. final concentrations ranging from 50 to 300 ,ug/ml. Two
MAbs were used as negative controls in parallel experiments, including purified IgG against major histocompatibility (MHC) class I antigen (HB95; ATCC) and the ammonium sulfate-precipitated culture supernatant of the myeloma cell line (described above).
RESULTS
Characterization of MAbs CJSm18-S1 to -S6. The sequence of the 19-amino acid peptide is highly conserved among the GTFs (Fig. 1) , and it was predicted by computer analysis to contain a hydrophilic alpha-forming unit (7). This peptide was able to elicit high-titer antibodies in mice immunized with a peptide-BSA conjugate. Antiserum titers of 1:1,000 could readily detect both peptide-BSA and peptide alone by ELISA. After fusion, six stabilized cell lines (CJSm18-S1 to -S6) were obtained after subcloning by limiting dilution. These six hybridomas produced IgG-type MAbs that reacted specifically with the peptide and GTFs (Table 1) . CJSm18-S3 exhibited better responses than the other five cell lines in producing ascites and was used for MAb generation. The titer of CJSm18-S3 ascites was determined to be 10-', and its isotype was defined as IgG2b. Affinity column-purified IgG of CJSm18-S3 reacted specifically with the peptide, GtfC, and GtfD but not with BSA (Fig. 2) . The MAb also recognized the crude extract and purified GtfC on the immunoblot (data not shown). These results confirmed that peptide-specific MAbs could recognize and react with the same sequence on the GTFs.
Specific inhibition of GTFs by MAbs. The ability of purified CJSm18-S3 to interfere with GTF enzymatic activities was examined by incubating the MAb with purified GtfC, GtfD, and the GtfB/C preparation, which contained both GtfB and GtfC (4) . The GtfC enzyme (2 mU) synthesized primarily insoluble glucan (70 to 75%) and some soluble glucan (25 to 30%), while GtfD synthesized soluble glucan exclusively under the standard assay conditions. Relative levels of both total and insoluble glucan synthesis were estimated in the presence of various concentrations of the CJSm18-S3 antibody. As shown in Fig. 3A , CJSm18-S3 had an inhibitory effect on both total and insoluble glucan synthesis by GtfC in a dose-dependent manner. The maximal inhibition of insoluble glucan-synthesizing activity was about 50%, while the inhibition was about 25 to 30% when total glucan synthesis was measured. Surprisingly, CJSm18-S3, even at a very high b Partially purified preparation containing both GtfB and GtfC (4) from S. mutans GS-5DD, in which the g#D gene is inactivated (14) .
Purified recombinant DNase of Epstein-Barr virus (2a) served as an irrelevant protein in the ELISA.
concentration (1:8 molar ratio of enzyme to MAb), had no effect on the enzymatic activity of GtfD. When the GtfB/C preparation was tested, CJSm18-S3 also inhibited its enzymatic activity for both total and insoluble glucan synthesis. In addition, CJSm18-S3 inhibited insoluble glucan synthesis by the crude enzyme preparation of GtfB (Fig. 3B) .
A polyclonal antibody, PJS-3 (4), was used as a positive control, while an MHC class I-specific MAb and ammonium sulfate-precipitated culture supernatant of P3-X63 served as negative controls in parallel experiments. assays (sta of insoluble glucans is closely associated with the attachment of S. mutans to smooth surfaces. The ability of CJSm18-S3 to inhibit the attachment of S. mutans was examined in an in vitro assay. When S. mutans MT-8148 (serotype c strain) was cocultured with CJSm18-S3 (MAb prepared by ammonium sulfate precipitation of hybridoma supernatants), adherence was significantly inhibited (Fig.  4A ). More than 50% inhibition was achieved when the protein concentration reached 300 ,ug/ml, and some inhibition (12 to 18%) was also observed in the control experiments with a similar preparation from the myeloma cell line (P3-X63).
To verify the specificity of the attachment inhibition, adherence assays with purified antibodies were performed. As shown in Fig. 4B , purified CJSm18-S3 significantly inhibited the attachment of S. mutans at a concentration of 100 p,g/ml. As negative controls, the affinity column-purified irrelevant antibodies had negligible effects even at higher concentrations. These results confirmed that the adherence inhibition was due to a specific interaction and also indicated that a nonspecific inhibition occurred when ammonium sulfate-precipitated hybridoma supernatant of MAbs was used. Specific adherence inhibition was also obtained with purified CJSm18-S3 when strain GS-5 was tested (data not shown). Therefore, CJSm18-S3 antibody, with a defined epitope located between amino acid residues 435 and 453 of GtfC, exhibited specificity in blocking both the enzymatic activity of GtfC and the attachment of S. mutans to glass surfaces. bility and demonstrated that a 19-amino-acid peptide conmAb pg/ml taining residues 435 to 453 of GtfC was able to reverse the Specificity of affinity column-purified IgG of CJSml8-S3.
inhibitory effect of a polyclonal antibody which neutralized at different concentrations (1, 3, and 10 Fg/ml) were GTF enzymatic activities (4) . To further examine the biological function of this amino-terminal conserved region, we :or reactivity with peptide (A), BSA (0), GtfC (U), GtfD gnrtdppieseii Aswihrcgie hscn Nase (+). ELISA was performed as described in Table 1 , generated peptide-specific MAbs which recognized this con-.Data presented are averageA405values for quadruplicate served region and inhibited insoluble glucan synthesis by tndard deviations for all antigens tested were .0.022).
GtfC and the attachment of S. mutans to glass surfaces. Purified GtfC or GtfD (50 ,ug/ml) was incubated for 15 min at 37°C with PBS (control; *) or different concentrations of the MAb (expressed as the ratio of enzyme to antibody). (B) Partially purified GtfB/C (75 ,ug/ml) or the crude enzyme preparation of GtfB (100 pLg/ml) was incubated with different concentrations of the MAb. The reaction mixtures were subsequently incubated at 37°C with a substrate containing [14C]glucose-sucrose without dextran (GtfC, GtfB/C, and GtfB) or in the presence of dextran (GtfD). Relative levels of total (shaded bars), insoluble (patterned bars), and soluble (open bars) glucan synthesized were then measured as described in the text. Data are expressed as means ± standard deviations for triplicate assays. CJSml8-S3 inhibited insoluble glucan synthesis by GtfC and GtfB but did not inhibit soluble glucan synthesis by either GtfC or GtfD.
These results suggest that the amino-terminal conserved region might be involved in insoluble glucan synthesis. This was supported by the following observations. First, CJSm18-S3 had no effect on the enzyme activity of GtfD, which also contains this 19-amino-acid sequence at a comparable position but synthesizes water-soluble glucan exclusively. Second, soluble glucan synthesis by GtfC, calculated as the difference between total and insoluble glucan formation, was also not affected by the MAb (Fig. 3) . Third, insoluble glucan synthesis by GtfB is also inhibited. Fourth, increased sucrose concentrations in the inhibition assays did not overcome MAb inhibition, suggested that the MAbs did not interfere with substrate binding. The fact that CJSm18-S1 to -S6 exhibited comparable patterns of inhibition on the enzymatic activities suggested that all six MAbs recognize the same epitope(s) on the peptide or GtfC.
The inhibition of GtfC enzymatic activities by the antipeptide MAb CJSm18-S3 is far from complete (25 to 30%) when total glucan synthesis is measured (Fig. 3) . These results were duplicated in another isotope-labeled incorporation assay described by Koga et al. (18) , which measured total glucan synthesis only. GtfD enzymatic activities were still not affected when examined in parallel experiments (data not shown). GtfC expressed from E. coli is able to synthesize 64% insoluble glucan under assay conditions identical to those described for this study (13) . It has also been shown that GtfC synthesizes a large amount of low-molecularweight glucans (9, 13) . Inhibition of the enzymatic activity of GtfC and GtfB but not of GtfD confirmed that the MAbs selectively inhibited the GTFs (GtfB and GtfC) responsible for insoluble glucan synthesis. Differential inhibition of glucan synthesis has also been demonstrated by an antiserum recognizing a peptide of 15 amino acids (342 to 356 of GtfB). This antiserum inhibited more than 90% of insoluble glucan synthesis by crude GTFs. However, it inhibited only 30 and 40% of soluble glucan and total glucan synthesis, respectively (6) . The basis for antibody-mediated inhibition of GTF enzymatic activities may involve direct blocking of functional domains and/or steric hindrance by configuration modifications due to antibody binding.
The reason for the preferential inhibition of insoluble glucan synthesis by CJSm18-S3 is unclear. One possible mechanism is that the antibody interferes with glucan branching. Additional experiments, such as structural analysis of the glucan synthesized in the presence of MAb, might provide information with which to address this hypothesis. Another possibility is that subtle conformational or structural differences exist in the molecules of GTFs, although they have identical primary sequences.
Of particular interest is the colonization of the cariogenic streptococci mediated by the GTFs and their de novo glucan synthesis. Insertional inactivation of the gtf genes has shown that both gtfB and gtiC are required for sucrose-dependent colonization in vitro, while thegtfD gene is less important (1, 13, 14) . Recent studies have further demonstrated the importance of GtfC in mediating the colonization of cariogenic streptococci. A mutated strain carrying a functional gtfB gene and inactivated gtfC was defective in colonization in vitro (13) . In addition, transformed S. milleri harboring the gtfC gene adhered to hard surfaces in the presence of sucrose, while S. milleni harboring only gtfB failed to do so (9) .
In this study, we used purified proteins and demonstrated that MAbs reactive with a subsequence peptide in the GTFs are capable of blocking the sucrose-dependent adherence of S. mutans. Our results also indicated that attachment inhibition through antibodies requires specificity in antigenantibody recognition. A polyclonal antibody, PJS-2 (4), which recognized GtfB and GtfC but was unable to inhibit their enzymatic activities, failed to block the sucrose-dependent adherence of S. mutans even at high titers of serum. Another polyclonal antibody, PJS-3, which specifically recognized and inhibited the enzymatic activities of GtfB and . Sucrose-dependent colonization of glass surfaces was tested in the presence of ammonium sulfate-precipitated MAbs (A) and purified IgGs (B). The number of adherent cells was determined turbidimetrically and expressed as a percentage of the total cell mass (percent cell adherence) as described before (12) . Samples in parallel experiments exhibited no significant difference in total cell mass. Adherence for the control (PBS added) was 67.5% ± 5.2% (mean ± standard deviation). Data are percent inhibition of adherence for triplicate cultures, calculated as 100 -mean % adherence for the controls, which was normalized to 100%. PJS-2 and PJS-3 (4) are control IgGs purified from rabbit antiserum. Ammonium sulfate-precipitated culture supernatant of CJSm18-S3 (-) and of X3-P63 (a) were used. Error bars represent standard deviations.
GtfC (4), blocked the attachment assayed in vitro (Fig. 4) . Although the mechanism of glucan-mediated adherence of S. mutans is unclear, it has been shown that de novo glucan synthesis is required for the in vitro sucrose-dependent adherence of S. mutans (18) . Therefore, the blocking of the attachment by MAb CJSm18-S3 in the present investigation is probably achieved through inhibition of glucan synthesis by both GtfB and GtfC or in ways other than by enzyme inhibition. Both GtfB and GtfC can be expressed on the surface of S. mutans (4, 9) . Thus, CJSm18-S3 might react with an epitope(s) which directly mediates sucrose-dependent adherence through an as yet unidentified mechanism.
Inhibition of attachment of S. mutans through active or passive immunization has been shown to be a potential means for the prevention of dental caries (reviewed in reference 23). Identification of the catalytic domain and/or highly conserved peptide segments in the GTFs is of tremendous importance to the development of a GTF-based vaccine. Several domains of functional importance in the GTFs have been identified. A catalytic site for sucrose binding and hydrolysis has been identified in the N terminus of the GTFs (16, 24, 25) . However, the antigenicity or immunogenicity of this domain has not yet been reported. In the C-terminal third of the GTFs, a glucan-binding region with repeating sequences has been identified (1). Tryptic fragments of this region from a GTF molecule can bind to glucan polymers (31) . Furthermore, a peptide construct (GLU) comprising four copies of a 22-mer peptide derived from the glucanbinding regions of S. downei Gtfl could elicit a serum IgG response which reacted with GTFs and inhibited glucan synthesis (28) . Similar to the domains for sucrose and glucan binding, the peptide sequence in the N-terminal conserved region identified by us (3, 4) is also functionally important. It would be interesting to assess the anticaries potential of the immunity induced by this peptide in an animal model. The specificity of the antipeptide MAb in recognizing GTFs and blocking the attachment of S. mutans provides important information for the possibility that this conserved region can serve as a good candidate for the development of a subunit vaccine for preventing dental caries.
